Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
This publication represents the views and expert; opinions of an IARC Working Group on the; Evaluation of Carcinogenic Risks to Humans,; which met in Lyon, February 2013.
This publication represents the views and expert; opinions of an IARC Working Group on the; Evaluation of Carcinogenic Risks to Humans which met in Lyon (France) June 3 -10, 2014.
This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 2-9 June 2015
Table of Contents:; PART I HEMATOLOGIC MALIGNANCIES; PART II AERODIGESTIVE MALIGNANCIES; PART III ENDOCRINE MALIGNANCIES; PART IV BREAST CANCER; PART V GENITOURINARY MALIGNANCIES; PART VI GASTROINTESTINAL MALIGNANCIES; PART VII SARCOMA; PART VIII MELANOMA; PART IX CENTRAL NERVOUS SYSTEM MALIGNANCIE…
Table of Contents:; Topical Therapy -- Eczema -- Urticaria -- Acne, Rosacea and Related Disorders -- Psoriasis and Other Papulosquamous Diseases -- Bacterial Infections -- Sexually Transmitted Infections -- Viral Infections -- Fungal Infections -- Exanthems and Drug Reactions -- Hypersensitivity S…
Table of Contents:; 1 Definitions and key elements in palliative care -- 2 Symptom assessment -- 3 Clinical decision making -- 4 Pain assessment and management -- 5 Fatigue -- 6 Cachexia -- 7 Dehydration -- 8 Anxiety and depression -- 9 Sleep disturbance -- 10 Chronic nausea and vomiting -- 11 Cons…
Table of Contents:; I BASIC PRINCIPLES AND CONSIDERATIONS OF RATIONAL CHEMOTHERAPY AND MOLECULAR TARGETED THERAPY -- BIOLOGIC AND PHARMACOLOGIC BASIS OF CANCER CHEMOTHERAPY --BIOLOGIC BASIS OF MOLECULAR TARGETED THERAPY -- PRINCIPLES OF CANCER IMMUNOTHERAPY -- SYSTEMATIC ASSESSMENT OF THE PATIENT W…
This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 6-13 October 2015
This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 2-9 February 2016
This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 24-31 May 2016